Xtandi 40mg is nonsteroidal antiandrogen formulation which is prescribed for treatment of prostate cancer. It is formulated having enzalutamide as main chemical ingredient having molecular formula C21H16F4N4O2S with molar mass of 464.44 g/mol. This medicine is selective antagonist to androgen receptor and prevents effects of testosterone & dihydrotestosterone in prostate gland. It has about 84.6% of bioavailability with protein binding ability of 97 to 98%. Metabolism of Xtandi 40mg takes place in liver with help of CYP2C8 & CYP3A4 and shows average elimination half life of 5.8 days.
We are offering 40mg Enzalutamide Capsule, which is approved by the FDA for the treatment of men with metastatic castrate-resistant prostate cancer that is no longer responding to chemotherapy. This capsule is used to treat men with a certain type of prostate cancer. Further, in order to avoid any flaw and ensure the quality, our offered 40mg Enzalutamide Capsule is strictly tested on various quality parameters under the supervision of quality controllers. It basically belongs to a class of drugs known as anti-androgens (anti-testosterone).